ArchiMed

Investor type

PE / VC

Founded

2014

AUM

$715 M

Location

France

$1-5 m

Investment Ticket

3-5 years

Investment Horizon

Series B

Investment Stage

Expansion

Exit Strategy

Investor profile last updated: 06 December, 2025

Profile

ArchiMed is an independent investment firm specialized in the Healthcare industries. It is a strategic and financial partner to European and North American companies operating in the Biopharma, Medtech, Diagnostics, Life Sciences, Healthcare IT, Consumer Health, Public Safety and Care Services sectors.

Industry

Business Services (B2B) Healthcare Services Security Software Education Edtech Financial Services Fintech Food and Beverage Foodtech Transportation MedTech LegalTech HealthTech

Region of investment

Europe

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
c45r6MZeEYmDJjkF c45r6MZeEYmDJjkF
c45r6MZeEYmDJjkF
avatar
c45r6MZeEYmDJjkF c45r6MZeEYmDJjkF
c45r6MZeEYmDJjkF
avatar
c45r6MZeEYmDJjkF c45r6MZeEYmDJjkF
c45r6MZeEYmDJjkF
avatar
c45r6MZeEYmDJjkF c45r6MZeEYmDJjkF
c45r6MZeEYmDJjkF
avatar
c45r6MZeEYmDJjkF c45r6MZeEYmDJjkF
c45r6MZeEYmDJjkF
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about ArchiMed

ArchiMed is located in France.
ArchiMed was founded in 2014.
ArchiMed invests in companies and startups in Business Services (B2B), Healthcare Services, Security, Software, Education, Edtech, Financial Services, Fintech, Food and Beverage, Foodtech, Transportation, MedTech, LegalTech, HealthTech.
ArchiMed invests in companies and startups in Europe.
ArchiMed invests in companies and startups at Series B.
ArchiMed usually invests $1-5 m on average.
ArchiMed has around $715m assets under management.